Back

Remnant cholesterol and mortality in 37.559 patients from LIPIDOGRAM 2004, 2006 and 2015 studies.

2 September 2024 (08:55 - 09:05)
Organised by: Logo
Congress Presentation Part of: Non-classical risk factors for heart disease revisited Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

5 More presentations in this session

Presentation thumbnail
Interplay between family History and polygenic risk for coronary heart disease: a cohort study among over 60 thousand individuals
Doctor C. Iribarren (Oakland, US)
Abstract Slides Video
Presentation thumbnail
Association of Life's Essential 8 metrics with mortality outcomes in US cancer survivors
Doctor W. Chen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Non-lipid metabolomic biomarkers are associated with adverse cardiac remodelling and cardiovascular outcomes
Doctor M. Sanghvi (London, GB)
Abstract Slides Video
Presentation thumbnail
AI-enhanced detection of coronary inflammation predicts 10-year risk for cardiac mortality and MACE in individuals with no or minimal coronary atherosclerosis on routine CCTA
Doctor K. Chan (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Identifying clinical phenotype clusters for coronary artery disease: a novel approach using clustering by unsupervised machine learning
Mr J. Holtrop (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Non-classical risk factors for heart disease revisited
Video

The Event

Event poster

ESC Congress 2024

2 September 2024 08:55 CET
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol, clinical characteristics and mortality in 41.767 patients from LIPIDOGRAM 2004-2015 studies - the factor analysis for mixed data cluster analysis
thumbnail
Congress Presentation
Long-term prognostic impact of remnant cholesterol distribution after percutaneous coronary intervention and coronary artery bypass graft: insights from a nationwide cohort
thumbnail
Congress Presentation
Elevated remnant cholesterol confers high risk of ASCVD without prompting lipid-lowering therapy: an unmet medical need

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources